Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04820387 · ClinicalTrials.gov registry record
Assessment of Remote Vital Signs for Telemedicine Applications
A clinical trial of Telemedicine and Physiology, sponsored by Johns Hopkins University.
- Active
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT04820387: Active study of Telemedicine and Physiology, sponsored by Johns Hopkins University.
NCT04820387 is a study of Telemedicine and Physiology that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 94 participants, below the 4,052-participant average among 18 other Telemedicine trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04820387, a study of Telemedicine and Physiology, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether vital signs can be extracted from video. A secondary purpose is to create a database, including raw video, of "ground truth" physiological data on human subjects in order to test current and/or future approaches developed to extract vital signs from video. This research may have an immediate impact on not only the assessment of risk for COVID-19 but also may provide a significant technological enhancement to Johns Hopkins Medicine's telemedicine capabilities.
Primary Outcome
The principal outcome is the capability to calculate a reliable and clinically useful measure of blood oxygenation from video. Our objective is to quantify SpO2 from video within +/- 0.5% from clinical standard.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Asthma & Allergy Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2026-12 |
What the registry record for NCT04820387 still lists
NCT04820387 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 4,052-participant average among 18 other Telemedicine trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Telemedicine appearing as the primary indexed condition, and to 0 interventions.
NCT04820387 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04820387 about?
NCT04820387 is a clinical study titled "Assessment of Remote Vital Signs for Telemedicine Applications". The purpose of this study is to determine whether vital signs can be extracted from video. A secondary purpose is to create a database, including raw video, of "ground truth" physiological data on human subjects in order to test current and/or future approaches developed to extract vital signs from ...
What is the current status of trial NCT04820387?
This trial is currently active not recruiting. The enrollment target is 94 participants. The study started on 2021-04-20. Estimated completion is 2026-12.
What conditions does trial NCT04820387 study?
This clinical trial studies the following conditions: Telemedicine, Physiology.
Who is sponsoring clinical trial NCT04820387?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04820387 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Telemedicine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04820387's enrollment target sits among peer trials
94 16th of 18 higher than 3 of 18 other Telemedicine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Telemedicine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Integrating Telehealth to Advance Lung Cancer Screening
RECRUITING · NA
-
Integrated Telemedicine Program Evaluation
RECRUITING · NA
-
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
RECRUITING · NA
-
The Actuate-CBC Study
RECRUITING
-
Telehealth-delivered HealthcaRe to ImproVe Care
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI